Newsletter

BioMedReports Cara Therapeutics Announces Positive Results Of Peripheral Opioid; POZEN Appoints Senior VP and Chief Business... http://t.co/yoqxKE9IsH
18hreplyretweetfavorite
BioMedReports Newsmakers: Gilead, Amedisys, Compugen, iCAD, Cara Therapeutics: U.S. stocks dipped and bonds slid after the F... http://t.co/5k6HLNS245
23hreplyretweetfavorite
BioMedReports Chembio Falling After Failing To Provide Timeline On Product Deployment; Ambit Announces Expiration of Hart-Sc... http://t.co/H4UcwzRRWJ
navigation
Benzinga.com supporter Seeking Alpha Certified